| Walid Ibrahim Dagher, MD | |
|
35 Pearl St Ste 100, Brockton, MA 02301-2866 | |
| (508) 588-8034 | |
| (508) 588-5969 |
| Full Name | Walid Ibrahim Dagher |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 35 Pearl St Ste 100, Brockton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225219173 | NPI | - | NPPES |
| 11010386A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 261906 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Norwood Hospital | Norwood, MA | Hospital |
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Signature Healthcare Brockton Hospital | Brockton, MA | Hospital |
| Morton Hospital | Taunton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent Specialists, Inc | 0648353888 | 19 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
If you are in love this Valentine's Day, you have more than one reason to celebrate.
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.
The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.
› Verified 5 days ago
| Entity Name | Ent Specialists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548319809 PECOS PAC ID: 0648353888 Enrollment ID: O20080212000418 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
If you are in love this Valentine's Day, you have more than one reason to celebrate.
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.
The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.
› Verified 5 days ago
| Entity Name | Ent Norwood Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265749907 PECOS PAC ID: 9234476318 Enrollment ID: O20190128002049 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
If you are in love this Valentine's Day, you have more than one reason to celebrate.
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.
The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Walid Ibrahim Dagher, MD 35 Pearl St Ste 100, Brockton, MA 02301-1195 Ph: (508) 588-8034 | Walid Ibrahim Dagher, MD 35 Pearl St Ste 100, Brockton, MA 02301-2866 Ph: (508) 588-8034 |
News Archive
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
If you are in love this Valentine's Day, you have more than one reason to celebrate.
Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications - opioids and non-steroidal anti-inflammatory drugs (NSAIDS) - have major drawbacks, including the potential for misuse and abuse and adverse effects that limit long-term use. While scientists have made great strides in understanding the physical and chemical processes that occur when people feel pain, new treatments with improved safety and effectiveness are still needed for the more than 76 million Americans with acute and chronic pain.
The Harvard Clinical Research Institute announced today that the DAPT Study has expanded into seven countries in the European Union. John Irving, MBChB, MRCP, M.D., consultant cardiologist at Ninewells Hospital in Dundee, United Kingdom, was the first European investigator to enroll patients into the study.
› Verified 5 days ago
H Dennis Snyder, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 35 Pearl St Ste 100, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-588-5969 | |
Russell S Shu, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St Ste 100, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-588-5969 | |
Douglas A O'brien, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St Ste 100, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-588-5969 | |
Kimberly Russell, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St Ste 100, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-588-5969 | |
Dr. Ameer Trilok Shah, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St Ste 200, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-897-0475 | |
Pratik S Pradhan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St Ste 100, Brockton, MA 02301 Phone: 508-588-8034 Fax: 508-588-5969 |